Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ABBV-085 |
Trade Name | |
Synonyms | Samrotamab Vedotin|ABBV 085|ABBV085 |
Drug Descriptions |
ABBV-085 (Samrotamab Vedotin) is an antibody-drug conjugate (ADC) consisting of a monoclonal antibody against leucine-rich repeat containing 15 (LRRC15) in conjugation with the cytotoxic agent, monomethyl auristatin E (MMAE), which may lead to cytotoxicity against LRRC15-expressing tumor cells (PMID: 29764866). |
DrugClasses | |
CAS Registry Number | 2052649-42-8 |
NCIT ID | C124134 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ABBV-085 | ABBV-085 | 0 | 1 |